ReX-C system
Sponsors
Dosentrx Ltd.
Conditions
Adherence, MedicationCystic FibrosisOncologySide Effect
Unknown Phase
Evaluation of ReX-C® System for Medication Adherence in Oncology Patients Taking Oral Oncolytics
SuspendedNCT04091711
Start: 2020-04-21End: 2023-02-28Target: 20Updated: 2021-09-20
Evaluation of the ReX-C System, in Patients Receiving CFTR Modulators for the Treatment of Cystic Fibrosis (CF).
NCT04215796
Start: 2020-05-12End: 2022-07-31Target: 10Updated: 2021-09-23